The Hidden Power of Strategic Advisory Networks

Advisory boards are one of the most underutilized strategic assets available to scaling companies, and one of the most misused when they are utilized. The gap between what a well-designed advisory network can deliver and what most companies actually get from their advisors is substantial. Most advisory relationships are primarily cosmetic. A company recruits a […]
Building Investor Momentum Before a Fundraise: The Pre-Process Strategy

The most successful fundraising processes look effortless from the outside. A company enters the market, generates multiple term sheets, creates competitive tension among investors, and closes on excellent terms within a defined window. The founders appear unhurried. The investors appear eager. This outcome is almost never the result of simply having a great company. It […]
Strategic Growth vs. Fundraising: What Actually Drives Valuation
A persistent confusion in the startup ecosystem is the conflation of fundraising success with company success. Companies that raise large rounds are treated as successful. Valuations are cited as evidence of company quality. The fundraising process is managed as if it were the primary strategic objective rather than a means to one. This confusion produces […]
Why Many Companies Raise Capital Too Early and What It Costs Them

There is immense social pressure in the startup ecosystem to raise capital early and often. Funding rounds are announced as milestones. Large raises are treated as evidence of company quality. Founders who have not raised are sometimes perceived as less serious than those who have. This pressure has produced a generation of companies that have […]
What Investors Look for Before a Company Is Ready for Capital

The most common misconception about fundraising is that investors are primarily evaluating financial projections. They are not. Financial projections for early-stage and growth-stage companies are understood by all parties to be educated guesses. Investors have seen enough projections that show hockey-stick growth by year three to be immunized against optimistic models. What investors are actually […]